Advertisement
  • Making Decisions About Breast Surgery

    Patients who opt for breast reconstruction after mastectomy tend to overestimate how happy they will be with the results, while those who do not get reconstruction tend to underestimate their future satisfaction.

    by Cici Zhang

  • A Better Way to Screen for Lynch Syndrome?

    Researchers say a next-generation sequencing test could improve screening in colorectal cancer patients for a hereditary syndrome that raises cancer risk. Some experts have concerns.

    by Cheryl Platzman Weinstock

  • Forward Look

    Treating Early-Stage Lung Cancer

    Efforts are underway to define role of high-dose radiation.

    by Stephen Ornes

  • Survivor Profile

    Family Matters

    After Shigeo Tsuruoka was diagnosed with stomach cancer, his family came together to help him. His daughter, Aki Smith, was by his side as he navigated treatment and recovery. Now she offers guidance to other stomach cancer patients and caregivers.

    by Kate Yandell

  • Q&A

    Keeping Options Open

    Research scientist Teresa Woodruff is determined to make fertility preservation accessible to more young adults and children with cancer.

    by Delia O'Hara

  • Liver Cancer on the Rise

    Liver cancer incidence and death rates are increasing rapidly. Although there is no screening test for the disease, minimizing risk factors—hepatitis B and C, smoking, obesity and type 2 diabetes—could prevent many cases from developing.

    by Sue Rochman

  • Is 3-D Mammography Better?

    A study enrolling patients compares a newer form of digital mammography to conventional 2-D digital mammography.

    by Marci A. Landsmann

  • When Cancer Survivors Get Another Cancer

    Patients diagnosed with a second cancer may be unnecessarily excluded from clinical trials.

    by Kate Yandell

  • Forward Look

    Young Survivors at Risk for HPV-Related Cancers

    Study finds low vaccination rates among teen survivors.

    by Kate Yandell

  • Targeting Brain Cancer

    Researchers are trying to understand brain cancer at the molecular level. Their goal is to find new, more effective therapies for this hard-to-treat disease.

    by Stephen Ornes